Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Socio-communicative Sensitivity
NCT03096249Phase 2Completed
- Sponsor
- KU Leuven
- Start
- Nov 2016
- Primary completion
- May 2017
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin nasal spray, sponsored by KU Leuven. Primary endpoints: Social Salience Frequency-Tagging Fast Periodic Visual Stimulation and Oddball Face Detection Fast Periodic Visual Stimulation Paradigm. Started Nov 2016; status: completed.
02
Drugs
oxytocin nasal spray
Beyond the preview
Go deeper on NCT03096249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03096249.